ArisGlobal Signs Agreement to Acquire Amplexor Life Sciences, Creating the Most Comprehensive Regulatory SaaS Platform for the Industry
The complementary pairing of these two leading Regulatory companies brings ...
Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
The complementary pairing of these two leading Regulatory companies brings ...
ArisGlobal recognized by research firm for growth and innovation in ...
MIAMI, FL-- February 3, 2023 - ArisGlobal, the leading provider ...
The new solution, Investigational Product RIMS, will provide key foundational ...
ArisGlobal Earns Two Spots on Built In's Best Places to ...
The next-generation, intelligent engine will set the new standard for ...
Nearly 50% of life sciences professionals are eager to invest ...
LifeSphere Safety increases its customer footprint, further solidifying its safety ...
ArisGlobal’s cloud safety product continues to grow global customer base ...
Market leading safety platform to lead six sessions across Europe ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved